-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-cancer-imaging_technical-brief.pdf
October 01, 2014 - abdomen, and bone in addition to obtaining medical histories, physical
examinations, and relevant laboratory
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-future_research.pdf
May 01, 2012 - settings to be clinics similar to where
most patients are seen, rather than academic health centers, laboratory
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/patient-monitoring-systems-rapid-review.pdf
December 01, 2024 - learning-generated alerts using the Modified Early Warning
Score (MEWS++) system, which integrates EMR, laboratory
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gestational-diabetes-screening-diagnosis_executive.pdf
October 01, 2012 - These
criteria reflect changes that have occurred in laboratory
glucose measurements over the years
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-tables-F1-4.xlsx
January 01, 2022 - to nabilone 250 ug titrated up to a max of 2 mg/day Max dose 240 mg/day NA NA NA NA 6 Short Other (laboratory
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c-screening_disposition-comments.pdf
November 27, 2012 - Guidelines for Laboratory Testing and Result Reporting of Antibody to Hepatitis C
Virus.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-1-app-F.xlsx
January 01, 2023 - to nabilone 250 ug titrated up to a max of 2 mg/day Max dose 240 mg/day NA NA NA NA 6 Short Other (laboratory
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-4-tables-F1-4.xlsx
January 01, 2022 - to nabilone 250 ug titrated up to a max of 2 mg/day Max dose 240 mg/day NA NA NA NA 6 Short Other (laboratory
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-tables-E-1-E-4.xlsx
January 01, 2023 - to nabilone 250 ug titrated up to a max of 2 mg/day Max dose 240 mg/day NA NA NA NA 6 Short Other (laboratory
-
effectivehealthcare.ahrq.gov/sites/default/files/09_infectiousdisease_potential_high_impact_june_2012.pdf
January 01, 2012 - Gold test), and/or chest x-ray results.
173,174
The current
recommended diagnostic procedure for laboratory
-
effectivehealthcare.ahrq.gov/sites/default/files/coronary-artery-disease-testing_executive.pdf
March 01, 2011 - A third trial reported that
there was no clinical or laboratory evidence of contrast-
induced nephropathy
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/antiplatelet-treatment_executive.pdf
September 01, 2013 - over ascertainment of conventional risk factors in the
populations of interest (e.g., clinical or laboratory
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2024-surv-rep-update-tables-e1-4.xlsx
January 01, 2024 - to nabilone 250 ug titrated up to a max of 2 mg/day Max dose 240 mg/day NA NA NA NA 6 Short Other (laboratory
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2025-surv-rep-update-tables-e1-4.xlsx
January 01, 2025 - to nabilone 250 ug titrated up to a max of 2 mg/day Max dose 240 mg/day NA NA NA NA 6 Short Other (laboratory